These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15502723)

  • 1. TNP-470, an angiogenesis inhibitor, attenuates the development of allograft vasculopathy.
    Denton MD; Magee C; Melter M; Dharnidharka VR; Sayegh MH; Briscoe DM
    Transplantation; 2004 Oct; 78(8):1218-21. PubMed ID: 15502723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of TNP-470 (AGM-1470) on the growth of rat rhabdomyosarcoma tumors of different sizes.
    Landuyt W; Theys J; Nuyts S; Drijkoningen M; Fowler J; Reijnders A; Liekens S; Neyts J; de Bruijn E; Anné J; Lambin P
    Cancer Invest; 2001; 19(1):35-40. PubMed ID: 11291554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of endothelin-1 improves survival and vasculopathy in rat cardiac transplants treated with cyclosporine.
    Simonson MS; Robinson AV; Schulak JA; Hricik DE
    Transplantation; 2002 Apr; 73(7):1054-9. PubMed ID: 11965031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats.
    Kin M; Torimura T; Ueno T; Nakamura T; Ogata R; Sakamoto M; Tamaki S; Sata M
    Int J Oncol; 2000 Feb; 16(2):375-82. PubMed ID: 10639583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of angiogenesis inhibitor TNP-470 against postoperative lung metastasis following removal of orthotopic transplanted human colon cancer: an experimental study.
    Oda H; Ogata Y; Shirouzu K
    Kurume Med J; 2001; 48(4):285-93. PubMed ID: 11830929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.
    Wang J; Xu R; Jin R; Chen Z; Fidler JM
    Transplantation; 2000 Aug; 70(3):447-55. PubMed ID: 10949186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A reduction in accelerated graft coronary disease and an improvement in cardiac allograft survival using low molecular weight heparin in combination with cyclosporine.
    Aziz S; Tada Y; Gordon D; McDonald TO; Fareed J; Verrier ED
    J Heart Lung Transplant; 1993; 12(4):634-43. PubMed ID: 8396435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.
    Gervaz P; Scholl B; Padrun V; Gillet M
    Liver; 2000 Apr; 20(2):108-13. PubMed ID: 10847478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatic metastasis in mice treated with cell-binding domain of human fibronectin and angiogenesis inhibitor TNP-470.
    Saito N; Mitsuhashi M; Hayashi T; Narumo C; Nagata H; Soyama K; Kameoka S; Harumiya S; Fujimoto D
    Int J Clin Oncol; 2001 Oct; 6(5):215-20. PubMed ID: 11723742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of fumagillin and its analogue TNP-470 on the function, morphology and angiogenesis of an oestrogen-induced prolactinoma in Fischer 344 rats.
    Stepień H; Grochal M; Zieliński KW; Mucha S; Kunert-Radek J; Kulig A; Stawowy A; Pisarek H
    J Endocrinol; 1996 Jul; 150(1):99-106. PubMed ID: 8708569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNP-470: an angiogenesis inhibitor in clinical development for cancer.
    Kruger EA; Figg WD
    Expert Opin Investig Drugs; 2000 Jun; 9(6):1383-96. PubMed ID: 11060750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470.
    Shusterman S; Grupp SA; Maris JM
    Med Pediatr Oncol; 2000 Dec; 35(6):673-6. PubMed ID: 11107144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral serine proteinase inhibitor (SERP-1) effectively decreases the incidence of graft vasculopathy in heterotopic heart allografts.
    Hausen B; Boeke K; Berry GJ; Morris RE
    Transplantation; 2001 Aug; 72(3):364-8. PubMed ID: 11502962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of TNP-470, an angiogenesis inhibitor, combined with ultrasound irradiation for human uterine sarcoma xenografts evaluated using contrast color Doppler ultrasound.
    Emoto M; Tachibana K; Iwasaki H; Kawarabayashi T
    Cancer Sci; 2007 Jun; 98(6):929-35. PubMed ID: 17433035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis inhibition with TNP-470, 2-methoxyestradiol, and paclitaxel in experimental pancreatic carcinoma.
    Ryschich E; Werner J; Gebhard MM; Klar E; Schmidt J
    Pancreas; 2003 Mar; 26(2):166-72. PubMed ID: 12604915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimus.
    Wang M; Qu X; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1996 Feb; 61(3):458-64. PubMed ID: 8610361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of the angiogenesis inhibitor TNP-470 on murine lymphoma/leukemia cells in vivo and in vitro.
    Norén-Nyström U; Eriksson M; Eriksson B; Roos G; Bergh A; Holmberg D
    Exp Hematol; 2003 Feb; 31(2):143-9. PubMed ID: 12591279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of angiogenesis to the progression of colon cancer: possible inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and hepatic metastasis.
    Takatsuka S; Yamada N; Sawada T; Ogawa Y; Maeda K; Ohira M; Ishikawa T; Nishino H; Seki S; Hirakawa-YS Chung K
    Int J Oncol; 2000 Aug; 17(2):253-8. PubMed ID: 10891532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNP-470 inhibits 7,12-dimethylbenz[a]anthracene-induced mammary tumor formation when administered before the formation of carcinoma in situ but is not additive with tamoxifen.
    Heffelfinger SC; Gear RB; Schneider J; LaDow K; Yan M; Lu F; Pyle AL; Warshawsky D
    Lab Invest; 2003 Jul; 83(7):1001-11. PubMed ID: 12861040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment.
    Landuyt W; Ahmed B; Nuyts S; Theys J; Op de Beeck M; Rijnders A; Anné J; van Oosterom A; van den Bogaert W; Lambin P
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):443-50. PubMed ID: 11173139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.